Research & Education

ELCC 2014: Late and Chronic Toxicities of New Targeted Therapies

March 31, 2014

Dr. Tony Mok, President of IASLC, offers an overview on most common toxicities related to targeted therapies in NSCLC. He highlights in particular skin, visual and gastrointestinal side-effects, but also underlines that these are generally manageable.

The European Lung Cancer Conference (ELCC) is organised by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC). Attendees benefit from educational and scientific updates provided by thoracic oncology specialists on different multidisciplinary topics important for research and clinical practice in the field of lung cancer.